Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8497)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nicolini D, Agostini A, Montalti R, Mocchegiani F, Mincarelli C, Mandolesi A, Robertson NL, Candelari R, Giovagnoni A, Vivarelli M. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. World J Gastroenterol 2017; 23(20): 3690-3701 [PMID: 28611522 DOI: 10.3748/wjg.v23.i20.3690] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i20/3690.htm |
| Number | Citing Articles |
| 1 |
Shuai Wang, Hefeng Geng, Yizhen Li, Ziang Xu, Kaisi Yang, Ling Yang, Fuhai Hui, Yingshi Zhang. Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis. Heliyon 2024; 10(9): e30759 doi: 10.1016/j.heliyon.2024.e30759
|
| 2 |
Michał Grąt, Marek Krawczyk, Jan Stypułkowski, Marcin Morawski, Maciej Krasnodębski, Michał Wasilewicz, Zbigniew Lewandowski, Karolina Grąt, Waldemar Patkowski, Krzysztof Zieniewicz. Prognostic Relevance of a Complete Pathologic Response in Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgical Oncology 2019; 26(13): 4556 doi: 10.1245/s10434-019-07811-z
|
| 3 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(01): e67 doi: 10.1055/a-2189-6353
|
| 4 |
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter, Malek Nisar. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie 2022; 60(01): e56 doi: 10.1055/a-1589-7568
|
| 5 |
Shamar Young, Tina Sanghvi, Sandeep Sharma, Cameron Richardson, Nathan Rubin, Masters Richards, Donna D'Souza, Siobhan Flanagan, Jafar Golzarian. Local recurrence following complete radiologic response in patients treated with transarterial chemoembolization for hepatocellular carcinoma. Diagnostic and Interventional Imaging 2022; 103(3): 143 doi: 10.1016/j.diii.2022.01.006
|
| 6 |
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, Rita Carlotta Santoro, Vito Barbieri, Girolamo Ranieri, Domenico Laganà. Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology. Cancers 2022; 15(1): 257 doi: 10.3390/cancers15010257
|
| 7 |
Quirino Lai, Alessandro Vitale, Tommaso Manzia, Francesco Foschi, Giovanni Levi Sandri, Martina Gambato, Fabio Melandro, Francesco Russo, Luca Miele, Luca Viganò, Patrizia Burra, Edoardo Giannini. Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics. Cancers 2019; 11(10): 1568 doi: 10.3390/cancers11101568
|
| 8 |
Piotr Remiszewski, Paweł Topolewski, Dariusz Łaski, Anna Drobińska. Outcomes of Bridging Therapy in Liver Transplantation for Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22): 6633 doi: 10.3390/jcm13226633
|
| 9 |
Deok Gie Kim, Jae Geun Lee, Dong Jin Joo, Soon Il Kim, Myoung Soo Kim. Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46871-9
|
| 10 |
Hongyao Chen, Renyi Yang, Xiaopeng Yu, Kexiong Li, Peisen Xue, Wei Peng, Puhua Zeng. Development of a Nomogram Using the Inflammatory Risk Score for Prognostication in Moderate and Advanced Hepatocellular Carcinoma Associated with Hepatitis B Virus. Balkan Medical Journal 2024; : 130 doi: 10.4274/balkanmedj.galenos.2024.2023-12-8
|
| 11 |
Quirino Lai, Fabio Melandro, Zoe Larghi Laureiro, Francesco Giovanardi, Stefano Ginanni Corradini, Flaminia Ferri, Redan Hassan, Massimo Rossi, Gianluca Mennini. Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis. World Journal of Gastroenterology 2018; 24(15): 1658-1665 doi: 10.3748/wjg.v24.i15.1658
|
| 12 |
Zili Hu, Xiaohui Wang, Yizhen Fu, Dinghua Yang, Zhongguo Zhou, Minshan Chen, Xin Song, Yaojun Zhang. Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study. International Journal of Surgery 2023; doi: 10.1097/JS9.0000000000000942
|
| 13 |
Yuanqiang Dai, Guolin Sun, Hongli Hu, Chun Wang, Hengyue Wang, Yanping Zha, Ying Sheng, Jiong Hou, Jinjun Bian, Lulong Bo. Risk factors for postoperative pulmonary complications in elderly patients receiving elective colorectal surgery: A retrospective study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1002025
|
| 14 |
Hugues Radovitch, Sarah Le Sagere, Bastien Cabarrou, Charlotte Maulat, Paul Boulard, Nadim Farès, Charline Zadro, Jean-Marie Peron, Bertrand Suc, Fatima-Zohra Mokrane, Fabrice Muscari. Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List. Transplantation Proceedings 2024; 56(8): 1774 doi: 10.1016/j.transproceed.2024.08.033
|
| 15 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(02): e213 doi: 10.1055/a-2189-8567
|
| 16 |
Leonardo Guedes Moreira Valle, Marcela Juliano Silva Cunha, Bruno Pagnin Schmid, Priscila Mina Falsarella, Marcelo Bruno de Rezende, Guilherme Eduardo Gonçalves Felga, Renata Emy Ogawa, Rodrigo Gobbo Garcia, Breno Boueri Affonso, Felipe Nasser, Francisco Leonardo Galastri. Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning. einstein (São Paulo) 2023; 21 doi: 10.31744/einstein_journal/2023AO0307
|
| 17 |
Wei Zhang, An-Hui Xu, Wei Wang, Yan-Hui Wu, Qian-Ling Sun, Chang Shu. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6265-1
|
| 18 |
Xiaopeng Yu, Renyi Yang, Zuomei He, Puhua Zeng. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators. Journal of Cancer Research and Clinical Oncology 2023; 149(11): 8969 doi: 10.1007/s00432-023-04830-y
|
| 19 |
S. Young, T. Sanghvi, R. Ragulojan, P. Torkian, S. Todatry, D. D'Souza, S. Flanagan, J. Golzarian. Local recurrence following a complete radiologic response in hepatocellular carcinoma patients: comparison of transarterial chemoembolisation and transarterial radioembolisation. Clinical Radiology 2024; 79(5): 371 doi: 10.1016/j.crad.2024.01.014
|
| 20 |
Maoting Zhou, Peng Zhang, Qi Mao, Yue Shi, Lin Yang, Xiaoming Zhang. Multisequence MRI-Based Radiomic Features Combined with Inflammatory Indices for Predicting the Overall Survival of HCC Patients After TACE. Journal of Hepatocellular Carcinoma 2024; : 2049 doi: 10.2147/JHC.S481301
|
| 21 |
Woong Ki Park, Pravin Kumar Joshi, Kwang-Woong Lee, Kyoung Bun Lee, Suk Kyun Hong, Kyung Chul Yoon, Jeong-Moo Lee, Jae-Hyung Cho, Nam-Joon Yi, Kyung-Suk Suh. Risk Factors of Tumor Recurrence After Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma. Transplantation Proceedings 2020; 52(1): 271 doi: 10.1016/j.transproceed.2019.09.013
|
| 22 |
Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. European Radiology 2020; 30(10): 5663 doi: 10.1007/s00330-020-06931-5
|
| 23 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2023; 61(04): e92 doi: 10.1055/a-2026-1240
|
| 24 |
Chao Jiang, Xiao-Dong Sun, Wei Qiu, Yu-Guo Chen, Da-Wei Sun, Guo-Yue Lv. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 7 doi: 10.1016/j.hbpd.2022.10.006
|
| 25 |
Xiaopeng Yu, Renyi Yang, Zuomei He, Kexiong Li, Puhua Zeng. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12013 doi: 10.1007/s00432-023-05037-x
|
| 26 |
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Mina Hibino, Paige Wright, Ari J. Cohen, Paul T. Thevenot. PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival. Cancer Immunology, Immunotherapy 2022; 71(6): 1453 doi: 10.1007/s00262-021-03087-z
|
| 27 |
Kelley G. Núñez, Tyler Sandow, Daniel Fort, Jai Patel, Mina Hibino, Ian Carmody, Ari J. Cohen, Paul Thevenot. Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers 2021; 13(19): 4765 doi: 10.3390/cancers13194765
|